Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

The native capsular polysaccharide of type III group B Streptococcus elicits a specific antibody response in only 60% of nonimmune human subjects. To enhance the immunogenicity of this polysaccharide, we coupled the type III polysaccharide to tetanus toxoid. Prior to coupling, aldehyde groups were i...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Wessels, M R, Paoletti, L C, Kasper, D L, DiFabio, J L, Michon, F, Holme, K, Jennings, H J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296886/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2243123/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114858
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!